CYBERDYNE Online Store

🔍

INVESTOR RELATION BACK NUMBER

SEARCH
2016.10.06
CYBERDYNE, INC.’s view on the research report released by Citron Research
2016.08.31
Anticipation of posting non-operating income
2016.08.26
CYBERDYNE, INC.’s view on the research report released by Citron Research (Part 2)
2016.08.26
Anticipation of posting in non-operating income and non-operating expense
2016.08.26
CYBERDYNE, INC.’s view on the research report released by Citron Research
2016.08.24
Analyst Interview : “CYBERDYNE’s Challenges to Shape the Future”
2016.08.24
Notice Regarding Confirmation of Details on the Issuance of Stock Options (Stock Acquisition Rights)
2016.08.19
CYBERDYNE, INC.’s view on the research report released by Citron Research
2016.08.16
Regarding certain media reports on CYBERDYNE, INC.
2016.08.10
Announcement of Financial Results for the Three Months Ended June 30, 2016
2016.07.26
Notice Regarding Establishment of a Subsidiary in the United States
2016.07.26
Notice Regarding the Issuance of Stock Options (Stock Acquisition Rights)
2016.07.21
CYBERDYNE, INC. enters into a service agreement with Kanagawa Prefecture on its “Project to Promote Development of Healthcare Robotics” ~Utilizing HAL ® for the elderly, and advancing preventive medicine~
2016.06.09
Notice Regarding Confirmation of Issuance of Stock Option (Stock Acquisition Rights)
2016.06.01
Notice Regarding Completion of Conversion of Convertible Bonds due 2017 to Common Stock
2016.05.24
Notice Regarding the Issuance of Stock Options (Stock Acquisition Rights)
2016.05.13
Announcement of Financial Results for the Year Ending March 31, 2016
2016.04.22
Notice of Exercise of Call Option on Convertible Bonds due 2017
2016.04.20
Notice regarding the agreement to enter into a consigned research and development contract with AMED (Development of Communication Aid Device for Persons with Disabilities including advanced ALS patients)
2016.04.18
Notice regarding the agreement to enter into a consigned research and development contract with AMED (investigator-initiated joint clinical trial by multiple facilities for the use of (Hybrid Assistive Limb [HAL]-HN01) as a new medical device for rare brain/spinal cord diseases)
BACK TO TOP